EMA Highlights: Green light for new medicines
by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.
by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.
Adding canola oil to the diet improved glycemic control and reduced cardiovascular risk in type 2 diabetes in one study, while an overall healthier diet reduced risk of… read more.
Despite some concerns to the contrary, the use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes,… read more.
A bihormonal “artificial pancreas” improved glycemic control and led to less hypoglycemia in type 1 diabetes patients, researchers reported here.
by Christine Clark – Insulin ranks among the top 10 ‘high-alert’ or high-risk medicines worldwide. (ref NPSA/2011/PSA003) It is also been an important cause of hospital admissions, mainly… read more.
National guidelines for lipids and blood pressure are likely to be a focus of attention at this year’s meeting of the American Diabetes Association.
Despite some concerns to the contrary, the use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes,… read more.
New guidelines for Type 2 diabetes screening in children are less effective and more costly than previous screening methods.
In the largest study to date of the relationship between sleep apnoea and diabetes, a new study of more than 8,500 Canadian patients has demonstrated a link between… read more.
Testing vitamin D alone is not enough – Combined assessment of parathyroid hormone along with vitamin D may be needed to assess the impact of vitamin D status… read more.
Testing vitamin D alone is not enough – Combined assessment of parathyroid hormone along with vitamin D may be needed to assess the impact of vitamin D status… read more.
From 2006 to 2008, nearly 75 per cent of patients with diabetes living in Ontario did not receive all of the tests recommended to properly monitor their disease…. read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.